C
COMPANY PROFILE
CellZome
Pharmaceutical company that discovers, develops, and commercializes kinase-targeted drugs
Revenue
$10–50M
Latest reported FY
Headcount
<100
Current team size
At a glance
- Founded
- 2000
- Headquarters
- Heidelberg, Germany
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later10 investors entered at this stage
Atlas Venture- AIAdvent International
- SCSchroders
- BPBiofrontier Partners
- ETEMBLEM Technology Transfer
- INInvesco
- SISofinnova Investments
- MEMedicxi
Index Ventures- EMEMBL
Employees mapped
36
incl. 2 AI specialists
Founders
Hidden — book a demo/100
quality score
Key operators
8
quality Hidden — book a demo/100
Potential founders
Hidden — book a demo
likely future founders
Talent movements
Hidden — book a demo in · Hidden — book a demo out
past 12 months
Source: Dealroom Talent Intelligence.
Alumni founders
Former CellZome employees who went on to found companies, sorted by Dealroom signal score.
LHLuma HealthEst. 2015
AIAdnan IqbalUnited States
Signal score77
HEHealxEst. 2014
David BrownUnited KingdomSignal score74
NONodTheraEst. 2016
Alan WattUnited KingdomSignal score70
ALAllcyteEst. 2017
Giulio Superti-FurgaAustriaSignal score51
DADaltontxEst. 2024
ARAdrian RossallUnited Kingdom
Signal score51
1 more alumni-founded companies in this previewBook a demo
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about CellZome on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CellZome on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.